Buy & Sell Recursion Pharmaceuticals Inc (RXRX) – Recursion Pharmaceuticals Inc Price Today
Aura AI Summary
Key Stats
- $1.76BMarket Cap
- HealthSector
- -24.6%3M Drawdown
- $1.18BEnterprise Value
- -Dividend Yield
- 10 daysTypical Hold Time
Recursion Pharmaceuticals Inc (RXRX) is currently valued at a market capitalization of $1.76B, with an enterprise value of $1.18B. Over the past 52 weeks, Recursion Pharmaceuticals Inc has traded between a low of $2.84 and a high of $6.79, highlighting its annual price range. Over the past three months, Recursion Pharmaceuticals Inc has recorded a drawdown of -24.6%, reflecting recent price volatility. On average, investors hold Recursion Pharmaceuticals Inc for approximately 10 days, indicating typical investor behavior on the platform.
About Recursion Pharmaceuticals Inc
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company leveraging artificial intelligence (AI) and machine learning to industrialize drug discovery. The company's unique approach combines one of the world's largest biological and chemical datasets with automated wet-lab and computational systems to map human biology and identify potential therapeutic candidates across a range of diseases, including oncology and rare diseases. Recursion aims to accelerate the traditionally slow and expensive process of drug development.
Most Recent News
Deadlines set for lead plaintiff appointments in class actions against Calix, AeroVironment, and Lucid Group.
Holzer & Holzer, LLC announced deadlines for investors to seek lead plaintiff status in shareholder class action lawsuits against Calix, AeroVironment, and Lucid Group. These lawsuits allege misleading statements or failure to disclose material facts...

Deadlines set for lead plaintiff in class actions against Graphic Packaging, Immutep, and Phreesia investors.
Holzer & Holzer, LLC announced deadlines for investors to seek lead plaintiff status in shareholder class action lawsuits against Graphic Packaging Holding Company, Immutep Limited, and Phreesia, Inc. These lawsuits allege misleading statements or no...

SpaceX targets historic $1.75T IPO with key filters for investors to consider before buying.
SpaceX is set to price its shares on June 11 and begin trading on June 12, aiming for a record $1.75 trillion valuation, making it the largest IPO ever. David Holtzman, former IBM chief scientist, offers three key filters for investors: explain the b...
